இரண்டாம் நிலை நோய்த்தொற்றுகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from இரண்டாம் நிலை நோய்த்தொற்றுகள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In இரண்டாம் நிலை நோய்த்தொற்றுகள் Today - Breaking & Trending Today

A CT scan for COVID merits a word of caution


A CT scan for COVID merits a word of caution
Updated:
Updated:
May 06, 2021 01:48 IST
Going by data and the risk factors, its widespread use in diagnosing the infectious disease needs to be questioned
Share Article
AAA
Going by data and the risk factors, its widespread use in diagnosing the infectious disease needs to be questioned
There are broadly three reasons why we perform tests in clinical medicine: diagnosis (what is the disease?), etiognosis (what caused a disease?), and prognosis (how will the disease evolve?). It is also important that the outcome of a test should guide treatment in some way, especially when it is being touted as being a monitoring test that provides unique information that cannot be obtained by easier means. Considering how widespread the use of computerised tomography (CT) scans of the thorax during the novel coronavirus pandemic has been, one would assume that the test would satisfy one, if not all the above criteria, f ....

United States , Pd Hinduja National Hospital , Research Centre , Cochrane Collaboration , New England Journal , Consultant Respirologist , National Hospital , Medical Research Centre , Lancelot Pinto , Clinical Medicine , Outcome Ofa Test , Monitoring Test , Use Of Computerised Tomography , Ct Scans , Novel Coronavirus Pandemic , Accurate Diagnostic Test , Accuracy Of Ct Scans In Diagnosing Covid 19 , Positive Rt Pcr , Overworked Laboratory Services , Accurate Test For Etiognosis , Ct Pattern , Severity Of Lung Involvement , The New England Journal Of Medicine , Risk Of Transmission The Virus , Possibility Of Other Lung Diseases , Blood Clots In The Lungs ,

The fight against Sars-CoV-2 in 2021: What's next?


The fight against Sars-CoV-2 in 2021: What’s next?
Metagenomics applied in a rapid clinical setting was unthinkable just a few years ago but now can be deployed by any hospital with local deployment.
Shares1
 
With more than 1.8 million  Covid-19-related deaths worldwide and more than 350,000 deaths in the United States alone, the battle against SARS-CoV-2 is raging on into 2021.
 
In 2020, we’ve certainly learned that better infrastructure for detection is critical in fighting diseases like Covid-19 – and metagenomics are key to better understanding and ultimately better treatment. As a consulting infectious disease physician and frontline worker, I’ve seen the battle first-hand and there is still a lot of work to do.  I was lucky to get the recently after seeing patients but we are still a long way off from controlling this pandemic. However, I’ve also seen that we’re getting closer to more effectively fighting this battle and new tools ....

United States , Broader Pathogens , Secondary Infections , Resistance Detection , Volume Testing , Smaller Teams , Weight Loss , Medical Devices , Healthcare Innovation , Medcity News , San Francisco , Life Sciences , Rock Health , Startup Advice , Startup Funding , Patient Monitoring System , Motion Sensors , Healthcare It , Foodborne Pathogens , Diagnostics Company , Diagnostic Platforms , Minimally Invasive Surgery , Laser Surgery , Health And Wellness , Employee Wellness Programs , Shanghai Innovation Center ,